Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?
Launched by HOPITAL SAINT ROCH · Oct 15, 2013
Trial Information
Current as of August 20, 2025
Completed
Keywords
ClinConnect Summary
Actually, patients presenting a sepsis with arterial lactate\> 2 mmol.l-1 must be considered as criticals, and if lactate\> 4 mmol.l-1 as septic shock. However, results are usually slow to obtain, especially if we want to respect the Surving Sepsis Campaign, which preconize antibiotic as soon as possible (first hour).
In admission room, arterial sample can't be easily done and usual results need more than 30 minutes. On the contrary, using analyzers like "EKF diagnostics Lactate Scout\*" can give results faster with capillary blood (15 seconds). We will compare this results with both veino...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years
- • S.I.R.S : 2 or more criteria (fever \> 38.3°C or hypothermia (core temperature \< 36°C) heart rate \> 90.min-1, tachypnea, altered mental status)
- • Suspected infection
- Exclusion Criteria:
- • Arterial sample by laboratory reference method no available
About Hopital Saint Roch
Hospital Saint Roch is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its state-of-the-art facilities and multidisciplinary approach, the hospital collaborates with a diverse team of healthcare professionals and researchers to conduct rigorous clinical studies across various therapeutic areas. Committed to ethical standards and patient safety, Hospital Saint Roch aims to contribute significantly to the medical community by translating research findings into effective treatments and enhancing health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, Alpes Maritimes, France
Patients applied
Trial Officials
Contenti Julie, M.D
Principal Investigator
Association pour la Formation l'Enseignement et la Recherche du Service de l'Accueil des Urgences
Jacques Levraut, PD,MD
Study Director
CHU de Nice, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials